NYSE:BCSF · New York Stock Exchange
+$0.04 today
Vol 0.40M · Avg 0.40M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Management quality matters because capital allocation choices determine how much of Bain Capital Specialty Finance, Inc. earnings power becomes long-term shareholder value. Use this page to compare BCSF returns on capital, executive context, insider transactions, ownership signals, and growth trends against peers, then decide whether leadership appears disciplined, aligned, and capable of compounding through changing market conditions.
Return Metrics
ROE, ROIC & ROA over time
ROE
8.8%
avg 6.8%
ROIC
6.5%
avg 3.6%
ROA
3.7%
avg 3.0%
Analysis
ROE is currently the strongest return metric at 8.8% versus its period average of 6.8%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Katherine Schneider | MD of Investor Relations & Secretary | — | — | — | — | — |
Sabrina Rusnak-Carlson | General Counsel | — | — | 47 | $9,560.00 | 0.01% |
Amit Joshi | Treasurer | — | — | 44 | $0.00 | <0.01% |
David Benjamin Gross-Loh | Managing Partner | — | — | 56 | $0.00 | <0.01% |
James Goldman | Chief Compliance Officer | — | — | 50 | $0.00 | <0.01% |
Michael Alexander Ewald | Chief Executive Officer & Director | — | — | 54 | $69,995.23 | 0.11% |
Michael Boyle | President & Director | — | — | 41 | $69,995.23 | 0.11% |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
1
$28,865.00
Sells
0
$0.00
Net Sentiment
+$28,865.00
Net buying
Most Active
Rusnak-Carlson Sabrina
1 transactions
Analysis
Insiders reported 1 buys worth $28,865.00 and 0 sells worth $0.00 over the last 12 months. That adds up to net buying of $28,865.00. Rusnak-Carlson Sabrina was the most active insider with 1 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | -47.7% | +33.2% (8yr)2 analysts |
| Revenue | N/A | N/A | +46.6% | +15.3% (8yr)2 analysts |
| Net Income | N/A | N/A | -24.6% | +34.8% (8yr)2 analysts |
| EBIT | N/A | N/A | -22.3% | +43.9% (8yr)2 analysts |
Analysis
Recent growth has been strongest in Revenue at +46.6% over three years. Forward estimates point to EBIT at +43.9% (8yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Goldman Sachs BDC, Inc.
NYSE:GSBD
$1.08B
ASA Gold and Precious Metals Limited
NYSE:ASA
$1.02B
Kayne Anderson BDC, Inc.
NYSE:KBDC
$901.70M
Carlyle Secured Lending, Inc.
NASDAQ:CGBD
$756.82M
PennantPark Floating Rate Capital Ltd.
NYSE:PFLT
$742.15M
Fidus Investment Corporation
NASDAQ:FDUS
$733.66M
New Mountain Finance Corporation
NASDAQ:NMFC
$675.33M
SLR Investment Corp.
NASDAQ:SLRC
$674.30M
Nuveen Churchill Direct Lending Corp.
NYSE:NCDL
$626.23M
Who manages BCSF?
Bain Capital Specialty Finance, Inc. (BCSF) lists 7 active executives. The top listed executive is Katherine Schneider, MD of Investor Relations & Secretary.
Are BCSF insiders buying or selling?
Recent insider activity shows net buying of $949.51T.
Explore More
Continue the stock analysis
Jump to another research area for this company.